Podcast
Questions and Answers
Which of the following is NOT a topical treatment for osteoarthritis?
Which of the following is NOT a topical treatment for osteoarthritis?
- Diclofenac gel
- Menthol
- Capsaicin cream
- Ibuprofen gel (correct)
What is the maximum daily dose of Diclofenac gel that can be applied to a single joint?
What is the maximum daily dose of Diclofenac gel that can be applied to a single joint?
- 16g (correct)
- 8g
- 20g
- 12g
What is the mechanism of action of capsaicin cream?
What is the mechanism of action of capsaicin cream?
- Inhibits prostaglandin synthesis
- Depletes substance P (correct)
- Inhibits COX-2 enzymes
- Increases local blood flow
What is the maximum recommended daily dose of acetaminophen?
What is the maximum recommended daily dose of acetaminophen?
Which of the following is a potential adverse effect of Diclofenac gel?
Which of the following is a potential adverse effect of Diclofenac gel?
Which of the following is NOT a recommended treatment for osteoarthritis?
Which of the following is NOT a recommended treatment for osteoarthritis?
What is the recommended frequency of application for Diclofenac topical solution (Pennsaid) for knee osteoarthritis?
What is the recommended frequency of application for Diclofenac topical solution (Pennsaid) for knee osteoarthritis?
What is the mechanism of action of NSAIDs in the treatment of osteoarthritis?
What is the mechanism of action of NSAIDs in the treatment of osteoarthritis?
Which of the following are potential risks associated with COX-2 inhibitors?
Which of the following are potential risks associated with COX-2 inhibitors?
What is the recommended duration for a trial of NSAIDs for pain?
What is the recommended duration for a trial of NSAIDs for pain?
Which of the following patients are at greatest risk for nephrotoxicity from NSAIDs?
Which of the following patients are at greatest risk for nephrotoxicity from NSAIDs?
Which of the following is NOT a combination product that includes an NSAID?
Which of the following is NOT a combination product that includes an NSAID?
What is the recommended frequency of monitoring serum creatinine (SCr) in patients taking NSAIDs?
What is the recommended frequency of monitoring serum creatinine (SCr) in patients taking NSAIDs?
Which of the following agents is NOT an NSAID?
Which of the following agents is NOT an NSAID?
What is the recommended dose of Celebrex for osteoarthritis?
What is the recommended dose of Celebrex for osteoarthritis?
Which of the following is NOT a factor that increases the risk of adverse effects from NSAIDs?
Which of the following is NOT a factor that increases the risk of adverse effects from NSAIDs?
What is the maximum daily dose of acetaminophen recommended for patients with osteoarthritis?
What is the maximum daily dose of acetaminophen recommended for patients with osteoarthritis?
What is the recommended treatment for osteoarthritis?
What is the recommended treatment for osteoarthritis?
What is a potential adverse effect of NSAIDs?
What is a potential adverse effect of NSAIDs?
What is a possible way to reduce the risk of GI complications associated with NSAIDs like Mobic?
What is a possible way to reduce the risk of GI complications associated with NSAIDs like Mobic?
What is the recommended starting dose for tramadol?
What is the recommended starting dose for tramadol?
What is the maximum recommended daily dose of tramadol?
What is the maximum recommended daily dose of tramadol?
What is the recommended duration of treatment with Glucosamine/Chondroitin?
What is the recommended duration of treatment with Glucosamine/Chondroitin?
Which of the following is NOT a common adverse effect of tramadol?
Which of the following is NOT a common adverse effect of tramadol?
Which of the following is an appropriate treatment option for osteoarthritis, according to the provided text?
Which of the following is an appropriate treatment option for osteoarthritis, according to the provided text?
Which of the following is considered a disease-modifying osteoarthritis drug (DMOAD)?
Which of the following is considered a disease-modifying osteoarthritis drug (DMOAD)?
Which of the following is NOT a potential adverse effect of glucosamine/chondroitin?
Which of the following is NOT a potential adverse effect of glucosamine/chondroitin?
What is the primary mechanism of action of hyaluronate injections?
What is the primary mechanism of action of hyaluronate injections?
Which of the following is NOT a symptom of osteoarthritis in the knee?
Which of the following is NOT a symptom of osteoarthritis in the knee?
Which of the following is a non-drug therapy option for osteoarthritis?
Which of the following is a non-drug therapy option for osteoarthritis?
What is the patient's name in the given case study?
What is the patient's name in the given case study?
Which of the patient's conditions is a risk factor for osteoarthritis?
Which of the patient's conditions is a risk factor for osteoarthritis?
What is NOT a goal of therapy for the patient's osteoarthritis?
What is NOT a goal of therapy for the patient's osteoarthritis?
What is a common concern related to osteoarthritis treatment for the patient?
What is a common concern related to osteoarthritis treatment for the patient?
What is the most likely reason the patient's right hand pain is worse after she does housework and uses the computer?
What is the most likely reason the patient's right hand pain is worse after she does housework and uses the computer?
What type of therapy could be recommended for the patient's hand osteoarthritis?
What type of therapy could be recommended for the patient's hand osteoarthritis?
What are the clinical manifestations of osteoarthritis?
What are the clinical manifestations of osteoarthritis?
What is a common risk factor for osteoarthritis?
What is a common risk factor for osteoarthritis?
Which of these joints is most commonly affected by osteoarthritis?
Which of these joints is most commonly affected by osteoarthritis?
Which of the following statements accurately describes the pathophysiology of osteoarthritis?
Which of the following statements accurately describes the pathophysiology of osteoarthritis?
What is the most common joint-related disease in patients over 75 years old?
What is the most common joint-related disease in patients over 75 years old?
What is the typical progression of osteoarthritis?
What is the typical progression of osteoarthritis?
A 55-year-old woman presents with joint pain and stiffness in her hands and knees. She also notes a crunching sound in her knees when she walks. What might these symptoms be indicative of?
A 55-year-old woman presents with joint pain and stiffness in her hands and knees. She also notes a crunching sound in her knees when she walks. What might these symptoms be indicative of?
Which of the following is NOT a common risk factor for osteoarthritis?
Which of the following is NOT a common risk factor for osteoarthritis?
Flashcards
Osteoarthritis
Osteoarthritis
A degenerative joint disease characterized by cartilage and bone destruction.
Incidence of Osteoarthritis
Incidence of Osteoarthritis
Osteoarthritis is more common in older adults, especially females over 75.
Joint Involvement
Joint Involvement
Commonly affects distal interphalangeal joints, hips, and knees.
Risk Factors
Risk Factors
Signup and view all the flashcards
Clinical Manifestations
Clinical Manifestations
Signup and view all the flashcards
Herberden’s Nodes
Herberden’s Nodes
Signup and view all the flashcards
Bouchard’s Nodes
Bouchard’s Nodes
Signup and view all the flashcards
No Systemic Symptoms
No Systemic Symptoms
Signup and view all the flashcards
Joint Pain Symptoms
Joint Pain Symptoms
Signup and view all the flashcards
Knee Osteoarthritis
Knee Osteoarthritis
Signup and view all the flashcards
Non-Drug Therapy
Non-Drug Therapy
Signup and view all the flashcards
Drug Therapy for OA
Drug Therapy for OA
Signup and view all the flashcards
JD's Profile
JD's Profile
Signup and view all the flashcards
Goals of Therapy
Goals of Therapy
Signup and view all the flashcards
Hand Osteoarthritis
Hand Osteoarthritis
Signup and view all the flashcards
Muscle Weakness
Muscle Weakness
Signup and view all the flashcards
Mobic
Mobic
Signup and view all the flashcards
NSAIDs
NSAIDs
Signup and view all the flashcards
PUD
PUD
Signup and view all the flashcards
GI complications
GI complications
Signup and view all the flashcards
Tylenol
Tylenol
Signup and view all the flashcards
Naproxen analgesic dose
Naproxen analgesic dose
Signup and view all the flashcards
Naproxen anti-inflammatory dose
Naproxen anti-inflammatory dose
Signup and view all the flashcards
NSAID adverse effects
NSAID adverse effects
Signup and view all the flashcards
Greatest risk for nephrotoxicity
Greatest risk for nephrotoxicity
Signup and view all the flashcards
Greatest risk for cardiovascular AEs
Greatest risk for cardiovascular AEs
Signup and view all the flashcards
Monitoring NSAIDs
Monitoring NSAIDs
Signup and view all the flashcards
COX-2 Inhibitors benefits
COX-2 Inhibitors benefits
Signup and view all the flashcards
Combination NSAID products
Combination NSAID products
Signup and view all the flashcards
Non-Pharmacologic Therapy
Non-Pharmacologic Therapy
Signup and view all the flashcards
Topical Therapy
Topical Therapy
Signup and view all the flashcards
Capsaicin Cream
Capsaicin Cream
Signup and view all the flashcards
Diclofenac Gel
Diclofenac Gel
Signup and view all the flashcards
Acetaminophen (Tylenol)
Acetaminophen (Tylenol)
Signup and view all the flashcards
Hepatotoxicity Risk
Hepatotoxicity Risk
Signup and view all the flashcards
NSAIDs Response Variability
NSAIDs Response Variability
Signup and view all the flashcards
Injection Therapy
Injection Therapy
Signup and view all the flashcards
Opioid Analgesics
Opioid Analgesics
Signup and view all the flashcards
Tramadol (Ultram®)
Tramadol (Ultram®)
Signup and view all the flashcards
Duloxetine (Cymbalta®)
Duloxetine (Cymbalta®)
Signup and view all the flashcards
Glucosamine/Chondroitin
Glucosamine/Chondroitin
Signup and view all the flashcards
Intra-Articular Corticosteroid Injections
Intra-Articular Corticosteroid Injections
Signup and view all the flashcards
Hyaluronate Injections (Synvisc)
Hyaluronate Injections (Synvisc)
Signup and view all the flashcards
Monitoring Parameters for OA
Monitoring Parameters for OA
Signup and view all the flashcards
Future Treatments for OA
Future Treatments for OA
Signup and view all the flashcards
Study Notes
Osteoarthritis
- Overview of osteoarthritis (OA) is presented, including the course, key features and management strategies
- Patient scenarios were given to illustrate the typical patient presentations in a pharmacy setting
Pathology
- OA is characterized by degenerative changes in the cartilage and associated bone.
- This results in increased destruction of cartilage and subsequent proliferation of cartilage and bone.
Etiology and Risk Factors
- Risk factors associated with osteoarthritis include:
- Genetic predisposition
- Joint misalignment
- Age
- Gender (more common in females)
- Race
- Hormonal status
- Joint trauma
- Overuse/sports
- Obesity
- Joint immobilization
- Muscle weakness
- Repetitive stress
- Major joint trauma
- Heredity
Incidence
- OA is observed more commonly in older patients.
- It's the most common joint-related disease, affecting almost 85% of patients over 75 years old.
- The severity of the disease increases with age.
- More common in females.
Joint Involvement
- Distal interphalangeal joint.
- Hips.
- Knees.
Clinical Manifestations
- Joint pain.
- Morning stiffness.
- Crepitus.
- Inflammation.
- Muscle atrophy.
- Asymmetric joint involvement.
- No systemic symptoms
- Instability of weight-bearing joints.
- Herberden's nodes.
- Bouchard's nodes.
- Symptom examples from a patient perspective:
- Pain when waking up.
- Tenderness/soreness after activity.
- Pain even when not active.
- Difficulty with daily tasks (e.g., getting up from a chair, going up and down stairs).
- Cracking/grating sounds/feelings with movement.
- Redness and swelling around joints
- Inability to perform activities due to stiffness and pain.
- Reduced muscle strength -Reduced coordination due to pain or stiffness -Overweight -Peptic ulcer disease -Hypertension -Diabetes
Goals of Therapy
- Relief of pain and discomfort.
- Maintenance of joint function and strength.
Treatment of OA
- Non-drug therapy.
- Drug therapy (based on hand, knee, or hip):
- Topical therapy
- Oral agents
- Supplements
- Injectables
Treatment of OA (continued)
- Non-pharmacological therapy:
- Psychological support
- Education
- Rest
- Physical activity/exercise
- Heat/Ice
- Physical Therapy
- Occupational Therapy
- Weight Loss
Medications for OA
-
NSAIDs:
- Mechanism of action (MOA): Inhibition of COX-1 and COX-2 enzymes.
- Dosing: Analgesic vs anti-inflammatory dose.
- Patient response varies.
- Adverse effects: GI upset, ulcers, bleeding, renal dysfunction, increased blood pressure, risk of stroke, MI and death
-
Possible patient at risk of nephrotoxicity and cardiovascular issues
-
COX-2 inhibitors:
- Lower incidence of GI bleeding
-
Combination products
- NSAID + PPI
- NSAID + misoprostol
- NSAID + H2 antagonist
-
Guidelines for NSAID use in OA:
- Avoid NSAIDs if possible for patients at high CV risk.
-
Opioid Analgesics:
- Used for breakthrough pain
- Start low and increase dosage gradually.
- Adverse effects: nausea, somnolence, constipation, dizziness
-
Tramadol:
- MOA: affinity for μ-receptor
- Dose: 25-50 mg every 4-6 hours, titrating to 200-300 mg per day.
- Adverse effects: nausea, vomiting, dizziness, constipation
-
Duloxetine:
- Adjunct medication
- Dose: 30mg/day for 1 week increasing gradually to 60mg daily.
- Avoid with tramadol
- Adverse effects: gastrointestinal issues
-
OTC Supplements:
- Glucosamine/chondroitin:
- MOA: stimulates proteoglycan synthesis.
- Dose: 500mg PO TID of glucosamine and 400mg PO TID of chondroitin.
- Slow onset (4 weeks), 3 month trial.
- Adverse effects: gas, bloating cramping and nausea
- Glucosamine/chondroitin:
-
Intra-articular corticosteroid injections:
- Used for isolated joints.
- Not more than every 4-6 months.
- Can be painful.
- Peak pain relief in 7-10 days
-
Hyaluronate injections (e.g., Synvisc™):
- Temporary increase in viscosity
- Injected weekly for 3-5 weeks.
- Maximum benefit in 8-12 weeks.
- Used for patients who do not tolerate other treatments or not suitable for surgery.
- Only local adverse effects (minor swelling).
-
Joint Replacement Surgery:
- Relieves pain at rest, restores joint function, and lasts 10-15 years.
- Newer materials last longer.
Monitoring Parameters
- Pain (at rest).
- Joint stability and function
- Risk of falling
- Degree of disability.
- Weight.
- Adverse drug reactions.
- Compliance with non-drug measures.
- Range of motion
- X-rays
- Quality of life (QOL) issues.
Future/Alternative Treatments
- Acupuncture.
- Strategies for targets: cartilage, synovial membrane and subchondral bone.
- Disease-modifying osteoarthritis drugs (DMOADs).
- Stem cell therapy.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Test your knowledge on topical treatments for osteoarthritis, including the use of Diclofenac gel and other NSAIDs. This quiz covers dosing, mechanisms of action, potential adverse effects, and recommended practices in managing osteoarthritis. Perfect for healthcare professionals and students in medical fields.